101 related articles for article (PubMed ID: 25455655)
41. A dramatic fetal outcome following transplacental transfer of dasatinib.
Berveiller P; Andreoli A; Mir O; Anselem O; Delezoide AL; Sauvageon H; Chapuis N; Tsatsaris V
Anticancer Drugs; 2012 Aug; 23(7):754-7. PubMed ID: 22421368
[TBL] [Abstract][Full Text] [Related]
42. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy.
Jackson N; Shukri A; Ali K
Br J Haematol; 1993 Sep; 85(1):203-4. PubMed ID: 8251394
[TBL] [Abstract][Full Text] [Related]
43. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature.
Mubarak AA; Kakil IR; Awidi A; Al-Homsi U; Fawzi Z; Kelta M; Al-Hassan A
Am J Hematol; 2002 Feb; 69(2):115-8. PubMed ID: 11835347
[TBL] [Abstract][Full Text] [Related]
44. Management of newly diagnosed chronic myeloid leukaemia during a twin pregnancy using leucapheresis: Case report and review of the literature.
Morris A; McMullin MF; Benson G
Transfus Apher Sci; 2015 Apr; 52(2):199-203. PubMed ID: 25634790
[TBL] [Abstract][Full Text] [Related]
45. Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia.
Claudiani S; Apperley JF; Deplano S; Khorashad J; Foroni L; Palanicawandar R; Perry R; Milojkovic D
Am J Hematol; 2016 Nov; 91(11):E480-E481. PubMed ID: 27467708
[No Abstract] [Full Text] [Related]
46. The combination of hydroxyurea and leucapheresis in the treatment of chronic myeloid leukaemia in pregnancy.
Fitzgerald JM; McCann SR
Clin Lab Haematol; 1993; 15(1):63-5. PubMed ID: 8472499
[TBL] [Abstract][Full Text] [Related]
47. Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.
Hermel DJ; Chiu V; Hermel MH; Tulpule A; Akhtari M
J Oncol Pharm Pract; 2019 Apr; 25(3):699-702. PubMed ID: 29207935
[TBL] [Abstract][Full Text] [Related]
48. Caring for Two: Pregnancy and Chronic Myeloid Leukemia.
Vassili C
Oncol Nurs Forum; 2015 May; 42(3):311-5. PubMed ID: 25901384
[TBL] [Abstract][Full Text] [Related]
49. Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
Santos FM; Ghelfond G; Seguro FS; Abdo ANR; Dalessandro T; Maciel FVR; Bassolli L; Rocha V; Bendit I
Am J Hematol; 2022 Feb; 97(2):E72-E74. PubMed ID: 34822180
[No Abstract] [Full Text] [Related]
50. Use of hydroxyurea in chronic myeloid leukemia during pregnancy: a case report.
Patel M; Dukes IA; Hull JC
Am J Obstet Gynecol; 1991 Sep; 165(3):565-6. PubMed ID: 1892181
[TBL] [Abstract][Full Text] [Related]
51. Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with alpha-interferon.
Baer MR
Am J Hematol; 1991 May; 37(1):66. PubMed ID: 2024648
[No Abstract] [Full Text] [Related]
52. Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Breccia M; Efficace F; Alimena G
Leuk Res; 2012 Jul; 36(7):804-5. PubMed ID: 22459331
[No Abstract] [Full Text] [Related]
53. Tyrosine kinase inhibitors (TKIs) used in the management of chronic myeloid leukaemia are associated with haematologic toxicities-Which TKI is the safest?
Eşkazan AE
Br J Clin Pharmacol; 2019 Oct; 85(10):2241-2243. PubMed ID: 31393022
[No Abstract] [Full Text] [Related]
54. Teratogenic Effect of Radotinib: Case Report.
Cheon J; Ahn JW; Park KM; Lee G; Jo YS
Anticancer Res; 2016 Dec; 36(12):6599-6601. PubMed ID: 27919989
[TBL] [Abstract][Full Text] [Related]
55. Tyrosine kinase inhibitors and pregnancy.
Abruzzese E; Trawinska MM; Perrotti AP; De Fabritiis P
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014028. PubMed ID: 24804001
[TBL] [Abstract][Full Text] [Related]
56. Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy.
Robertson HF; Milojkovic D; Butt N; Byrne J; Claudiani S; Copland M; Gallipoli P; Innes AJ; Knight K; Mahdi AJ; Parker J; Virchis A; Apperley JF
Br J Haematol; 2024 May; ():. PubMed ID: 38698705
[TBL] [Abstract][Full Text] [Related]
57. Acute myeloid leukaemia in pregnancy.
McGregor AK; Das-Gupta E
Br J Haematol; 2015 Aug; 170(4):441-2. PubMed ID: 26104019
[No Abstract] [Full Text] [Related]
58. Tyrosine kinase inhibitor-induced carotid stenosis: A case report.
Hersant J; Gardembas M; Leftheriotis G; Vandeputte P; Abraham P; Henni S
Leuk Res Rep; 2019; 12():100171. PubMed ID: 31194170
[TBL] [Abstract][Full Text] [Related]
59. Myelogenous Leukaemia and Pregnancy : (A Report of Two Cases).
Miles FT; Wheeler D
Can Med Assoc J; 1945 Apr; 52(4):407-8. PubMed ID: 20323415
[No Abstract] [Full Text] [Related]
60. Managing pregnancy in chronic myeloid leukaemia.
Palani R; Milojkovic D; Apperley JF
Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
